Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

116

...

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
J07BH01	ROTASIIL, ROTAVIRUS VACCINE, LIVE ATTENUATED (ORAL LIQUID)	BioTech	Rotavirus bovine-human , live attenuated -		Liquid	2,822,069 L.L
L04AB01	ENBREL	BioTech	Etanercept - 50mg	50mg	Injectable solution	52,197,598 L.L
S01LA04	LUCENTIS	BioTech	Ranibizumab - 10mg/ml	10mg/ml	Injectable solution	51,255,093 L.L
L04AB01	ENBREL	BioTech	Etanercept - 50mg	50mg	Injectable solution	52,197,598 L.L
S01LA05	EYLEA	BioTech	Aflibercept - 40mg/ml	40mg/ml	Injectable solution	65,161,855 L.L
L04AB01	ERELZI	BioTech	Etanercept - 50mg	50mg	Injectable solution	55,116,226 L.L
S01LA06	BEOVU	BioTech	Brolucizumab - 120mg/ml	120mg/ml	Injectable solution	68,669,378 L.L
J07BK01	VARICELLA VACCINE LIVE	BioTech	Varicella-herpes zoster virus (Oka strain), grown in human diploid cells (SV-cell line), live attenuated -		Injectable suspension	3,104,276 L.L
L04AB01	ERELZI	BioTech	Etanercept - 50mg	50mg	Injectable solution	38,118,333 L.L
L04AB01	ALTEBREL	BioTech	Etanercept - 25mg/0.5ml	25mg/0.5ml	Injectable solution	27,383,989 L.L
R03DX05	XOLAIR	BioTech	Omalizumab - 150mg	150mg	Injectable lyophilised powder for solution+diluent	50,309,160 L.L
L04AB01	ENBREL	BioTech	Etanercept - 25mg	25mg	Injectable solution	28,768,353 L.L
R03DX05	XOLAIR	BioTech	Omalizumab - 150mg	150mg	Injectable solution	37,110,724 L.L
L04AB01	ERELZI	BioTech	Etanercept - 25mg	25mg	Injectable solution	24,044,817 L.L
L04AB01	ETANERREL	BioTech	Etanercept - 25mg/0.5ml	25mg/0.5ml	Injectable solution	5,085,100 L.L
L04AB01	ETANERREL	BioTech	Etanercept - 50mg/ml	50mg/ml	Injectable solution	9,756,719 L.L
L04AB02	IXIFI	BioTech	Infliximab - 100mg	100mg	Injectable powder for concentrate for solution	23,911,751 L.L
J07CA09	HEXAXIM	BioTech	Diphteria Toxoid - ?20IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg		Injectable suspension	4,462,901 L.L
L04AB02	REMICADE	BioTech	Infliximab - 100mg	100mg	Injectable concentrated powder for solution	30,111,023 L.L
L04AB02	REMSIMA	BioTech	Infliximab - 100mg	100mg	Injectable concentrated powder for solution	24,977,587 L.L
L01FA01	MABIXEN 100	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	22,183,393 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	91,882,704 L.L
L01FA01	MABIXEN 100	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	11,091,696 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	179,063,666 L.L
L01FA01	MABTHERA	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrated solution	35,722,424 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	52,597,003 L.L
L01FA01	RITUXIREL	BioTech	Rituximab - 100mg	100mg/10ml	Injectable concentrated solution	11,708,063 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	179,063,666 L.L
L01FA01	RIXATHON	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	33,968,541 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	91,457,321 L.L

...

116

...